Videos tagged '2021 SNO Pediatric Meeting'
-
04:51
BIOL-10_Yiping He
June 6, 2021
BIOL-10 DISTRIBUTION AND VULNERABILITY OF TRANSCRIPTIONAL OUTPUTS ACROSS THE GENOME IN MYC-AMPLIFIED MEDULLOBLASTOMA CELLS Contact Presenter Rui Yang1, Wenzhe Wang2, Meichen Dong3, Kristen Roso...
-
04:48
EMBR-01_Gintvile Valinciute
June 6, 2021
EMBR-01 CLASS I HDAC INHIBITORS AND PLK1 INHIBITORS SYNERGIZE IN MYC-AMPLIFIED MEDULLOBLASTOMA Contact Presenter Gintvile Valinciute1,2, Jonas Ecker1,2, Florian Selt1,2, Thomas Hielscher3, Chri...
-
05:54
EMBR-04_Michael Goldstein
June 6, 2021
EMBR-04 BET INHIBITION TARGETS RADIOTHERAPY RESISTANCE IN H3K27ME3-DEFICIENT GROUP 3 MEDULLOBLASTOMA Contact Presenter Nishanth Gabriel1, Kumaresh Balaji1,2, Matthew Inkman1, Kay Jayachandran1, J...
-
04:04
EMBR-10_Sara Badodi
June 6, 2021
EMBR-10 INOSITOL TREATMENT INHIBITS MEDULLOBLASTOMA THROUGH SUPPRESSION OF EPIGENETIC-DRIVEN METABOLIC ADAPTATION Contact Presenter Sara Badodi1, Nicola Pomella1, Xinyu Zhang1, Gillian Morrison2,...
-
04:51
EMBR-17_Tejpal Gupta
June 6, 2021
EMBR-17 DE-INTENSIFICATION OF RADIOTHERAPY IN RIGOROUSLY DEFINED LOW-RISK WNT-SUBGROUP MEDULLOBLASTOMA IS ASSOCIATED WITH UNACCEPTABLY HIGH RISK OF NEURAXIAL FAILURE: RESULTS FROM THE PROSPECTIVE F...
-
05:22
EMBR-20_Alberto Delaidelli
June 6, 2021
EMBR-20 ELONGATION CONTROL OF MRNA TRANSLATION DRIVES GROUP 3 MEDULLOBLASTOMA Contact Presenter Alberto Delaidelli1, Gian Luca Negri1, Que Xi Wang1, Albert Huang1, Simran Sidhu1, Joyce Zhang1, Yu...
-
05:45
EMBR-21_Alberto Delaidelli
June 6, 2021
EMBR-21 CLINICALLY TRACTABLE OUTCOME PREDICTION OF GROUP 3/4 MEDULLOBLASTOMA BASED ON TPD52 IMMUNOHISTOCHEMISTRY: A MULTICOHORT STUDY Contact Presenter Alberto Delaidelli1, Christopher Dunham2, M...
-
05:19
EMBR-22_David Bakhshinyan
June 7, 2021
EMBR-22 RATIONAL DEVELOPMENT OF SYNERGISTIC THERAPIES ALONGSIDE BMI1 INHIBITION FOR GROUP 3 MEDULLOBLASTOMA Contact Presenter David Bakhshinyan1, Ashley A Adile1, Chitra Venugopal1, Kevin Brown2,...
-
06:00
EPCT-14 _Robbie Majzner
June 8, 2021
EPCT-14 GD2 CAR T-CELLS MEDIATE CLINICAL ACTIVITY AND MANAGEABLE TOXICITY IN CHILDREN AND YOUNG ADULTS WITH H3K27M-MUTATED DIPG AND SPINAL CORD DMG Contact Presenter Robbie Majzner, Sneha Ramakri...
-
05:09
EPCT-19_Taylor Dismuke
June 6, 2021
EPCT-19 DRUG RESISTANCE IN MEDULLOBLASTOMA ADDRESSED WITH OLIG2 INHIBITOR, CT-179 Contact Presenter Taylor Dismuke, Chaemin Lim, Timothy Gershon; UNC-CH, Chapel Hill, NC, USA Patients with med...
-
05:42
EPCT-25_Yutong Guo
June 6, 2021
EPCT-25 SMO PROTEIN DEPLETION IN SHH MEDULLOBLASTOMAS USING MICROBUBBLE-ENHANCED ULTRASOUND AND SIRNA LOADED CATIONIC NANOPARTICLES Contact Presenter Yutong Guo1, Hohyun Lee1, Zhou Fang1, Anastas...
-
05:03
EPEN-01_Amir Arabzade
June 6, 2021
EPEN-01 C11ORF95-RELA DICTATES ONCOGENIC TRANSCRIPTIONAL PROGRAMS TO DRIVE AGGRESSIVE SUPRATENTORIAL EPENDYMOMA Contact Presenter Amir Arabzade1, Yanhua Zhao2, Srinidhi Varadharajan2, Hsiao-Chi C...